GRK2 and hyperlipidemia: Based on these findings, it might be expected that targeted GRK2+/− deletion would lead to enhanced chemokine signalling which would propagate inflammatory cell recruitment in vivo and augment atherosclerotic lesion formation in GRK2+/− mice with hyperlipidaemia.